February 2026 Prescription Drug Affordability Board Meeting
- Date and time: February 23rd, 2026 9:00 am
Public Comment
The Board has set aside an opportunity for public comment during the meeting. Public comments must concern an agenda item and are limited to one minute and thirty seconds per comment. If you are interested in registering to make a public comment, please email [email protected] no later than the close of business on Wednesday, February 18, 2026, and provide:
- Your name
- Your address
- The agenda item your comment will address. PDAB staff will reach out to you directly to confirm your reservation or provide additional detail.
Written Comment
The public may also submit written comments on the Board's pending decisions, or general comments regarding the Board's work, to [email protected]. Please submit any written comments, concerning this agenda no later than the close of business on Wednesday, February 18, 2026. Please utilize the subject line “February 2026 Board Comments.”
Agenda and Meeting Materials
- Agenda - PDF - 121.26 KB
- Minutes - PDF - 109.43 KB
- Meeting Recording
- 02.23.2026 Board Cost Review Study: Preliminary Policy Review Recommendations - PDF - 1.46 MB
- Ozempic: Upper Payment Limit Framework- Version 2 (2/2/26) - PDF - 294.77 KB
- Ozempic: Upper Payment Limit Framework- Presentation (Updated 2/18/26) - PDF - 295.68 KB
- Trulicity: Upper Payment Limit Framework - Version 2 (2/2/6) - PDF - 161.96 KB
- Trulicity: Upper Payment Limit Framework- Presentation (Updated 2/18/26) - PDF - 155.78 KB
The following comment packets are applicable for the 2/23/26 Board Meeting:
2/23/2026 Board Meeting Comments:
Written Comment Packet - PDF - 919.5 KB
- Diabetes Patient Advocacy Coalition
- Eli Lilly
- Maryland Tech Council
- Patients Rising
2/17/2026 Framework Comments (Ozempic and Trulicity):
Written Comment Packet - PDF - 422.27 KB
- Diabetes Patient Advocacy Coalition
- EACH/PIC
- Novo Nordisk
1/26/2026 Board Meeting Comments (Reposted):
Written Comment Packet - PDF - 4.17 MB
- AARP
- Diabetes Patient Advocacy Coalition
- Community Access National Network (CANN)
- EACH/PIC Coalition
- Eli Lilly
- Let My Doctors Decide Action Network
- National Infusion Center Association and Infusion Accession Foundation
- Value of Care Coalition